Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2022-501221-21-00Phase 4Completed
Phase 4, randomised trial of propofol, bupivacaine and ropivacaine in hip osteoarthritis and knee osteoarthritis (OA) (2 arms), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: Early independent ambulation. Started Nov 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2022-501221-21-00.